Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Myelodysplastic syndrome+3

Recruiting

Registered drugNo placebo

Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Registered drugNo placebo

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Myelodysplastic syndrome+2

Recruiting

InvestigationalNo placebo

Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Myelodysplastic syndrome+5

Recruiting

InvestigationalNo placebo

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:AZD3632

Contact Research Centre

Myelodysplastic syndrome+3

Recruiting

Registered drugNo placebo

Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Busulfan

Contact Research Centre

Myelodysplastic syndrome

Recruiting

InvestigationalNo placebo

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Momelotinib Dihydrochloride Monohydrate

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

InvestigationalNo placebo

Study of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Momelotinib Dihydrochloride Monohydrate

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Registered drugNo placebo

Study of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Treosulfan

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Registered drugNo placebo

Study on Metformin for Preventing Leukemia in Patients with Clonal Cytopenia and Low-Risk Myelodysplastic Syndromes

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Metformin Hydrochloride

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Registered drugNo placebo

Study Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelodysplastic syndrome+3

Recruiting

Registered drugNo placebo

Study on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drug

Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you

53 trials match your criteria

Myelodysplastic syndrome+3

Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

Myelodysplastic syndrome+1

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Myelodysplastic syndrome+2

Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

Myelodysplastic syndrome+5

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

Myelodysplastic syndrome+3

Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Myelodysplastic syndrome

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

Myelodysplastic syndrome+1

Study of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment

Myelodysplastic syndrome+1

Study of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome

Myelodysplastic syndrome+1

Study on Metformin for Preventing Leukemia in Patients with Clonal Cytopenia and Low-Risk Myelodysplastic Syndromes

Myelodysplastic syndrome+1

Study Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Myelodysplastic syndrome+3

Study on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers

Myelodysplastic syndrome

Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.